{"news_desk": "Foreign", "print_page": "7", "subsection_name": null, "section_name": "Health", "byline": {"original": "By DONALD G. McNEIL Jr", "person": [{"middlename": "G.", "firstname": "Donald", "role": "reported", "lastname": "McNEIL", "rank": 1, "qualifier": "Jr", "organization": ""}]}, "abstract": null, "type_of_material": "News", "word_count": "1400", "keywords": [{"rank": "1", "value": "Epidemics", "is_major": "N", "name": "subject"}, {"rank": "11", "value": "Sanofi SA", "is_major": "N", "name": "organizations"}, {"rank": "12", "value": "Wellcome Trust", "is_major": "N", "name": "organizations"}, {"rank": "13", "value": "World Economic Forum", "is_major": "N", "name": "organizations"}, {"rank": "14", "value": "World Health Organization", "is_major": "N", "name": "organizations"}, {"rank": "15", "value": "Davos (Switzerland)", "is_major": "N", "name": "glocations"}, {"rank": "16", "value": "Africa", "is_major": "N", "name": "glocations"}, {"rank": "2", "value": "Vaccination and Immunization", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Ebola Virus", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Zika Virus", "is_major": "N", "name": "subject"}, {"rank": "5", "value": "MERS (Middle East Respiratory Syndrome)", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Nipah Virus", "is_major": "N", "name": "subject"}, {"rank": "7", "value": "Gates, Bill and Melinda, Foundation", "is_major": "N", "name": "organizations"}, {"rank": "8", "value": "GlaxoSmithKline PLC", "is_major": "N", "name": "organizations"}, {"rank": "9", "value": "Pfizer Inc", "is_major": "N", "name": "organizations"}, {"rank": "10", "value": "Merck & Company Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "Japan, Norway and two foundations have pledged money to devise a strategy to speed up the international response to viral threats.", "pub_date": "2017-01-18T22:00:16+0000", "document_type": "article", "source": "The New York Times", "snippet": "Japan, Norway and two foundations have pledged money to devise a strategy to speed up the international response to viral threats....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2017/01/19/science/19VACCINE/19VACCINE-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2017/01/19/science/19VACCINE/19VACCINE-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2017/01/19/science/19VACCINE/19VACCINE-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2017/01/19/science/19VACCINE/19VACCINE-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2017/01/19/science/19VACCINE/19VACCINE-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2017/01/19/science/19VACCINE/19VACCINE-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2017/01/18/health/partnership-epidemic-preparedness.html", "slideshow_credits": null, "blog": [], "_id": "587fe57795d0e0392607b779", "headline": {"main": "Donors and Drug Makers Offer $500 Million to Control Global Epidemics", "print_headline": "Donors and Drug Makers Offer $500 Million to Fight Epidemics"}}